s of historical facts. These statements are subject to
uncertainties and risks including, but not limited to, product and service
demand and acceptance, changes in technology, economic conditions, the impact
of competition and pricing, government regulation, and other risks contained
in reports filed by the company with the Securities and Exchange Commission.
All such forward-looking statements, whether written or oral, and whether made
by or on behalf of the company, are expressly qualified by the cautionary
statements and any other cautionary statements which may accompany the
forward-looking statements. In addition, the company disclaims any obligation
to update any forward-looking statements to reflect events or circumstances
after the date hereof.
For more information, please contact: Investor contact: Hawk Associates Julie Marshall or Grace Huang Tel: +1-305-451-1888 Email: email@example.com DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE CONDENSED CONSOLIDATED BALANCE SHEETS June 30, December 31, 2010 2009 US$ US$ (unaudited) ASSETS CURRENT ASSETS: Cash and cash equivalents 6,540,009 1,151,721 Accounts receivable, less allowance for doubtful accounts of $77,783 and $102,939 8,867,002 6,891,291 Other receivables 2,765,248 1,499,111 Prepayment and other current assets 4,611,990 1,691,387 Inventory, net 3,165,490 2,326,126 Total Current Assets 25,949,739 13,559,636 Property and equipment, net 2,803,429 2,862,625 Tax receivable 1,926,290 1,362,372 Total assets 30,679,458 17,784,633 LIABILITIES AND SHAREHOLDERS' EQUITY Short-term borrowings 1,474,610 1,464,770 Accounts payable 16,675 93,770 Advances from customers 92,606 174,253 Accrued expenses and other current liabilities 263,076 336,412 Tax payable 6,111,966 4,993,387 Warranty obligation 179,956 178,755 Warrants Liability 251,606 -- Due to officer -- 3,861 Total current liabilities 8,390,495 7,245,208 Commitments and contingency -- -- Shareholders'
Page: 1 2 3 4 5 6 7 8 9 10 11 12 Related medicine technology :1
|SOURCE Dehaier Medical Systems Ltd.|
Copyright©2010 PR Newswire.
All rights reserved
. Dehaier Medical Systems Announces Closing of Initial Public Offering on NASDAQ2
. Dehaier Medical Systems Announces First Quarter Net Income Up 54%3
. Dehaier Medical Systems Announces New Exclusive China Distribution Agreement with Welch Allyn, Further Broadening Companys Product Lines4
. Dehaier Medical Systems Chief Executive Officer To Ring NASDAQ Stock Market Closing Bell5
. Dehaier Medical Systems to Present to Investors at Global Hunter Securities 2010 China Investor Conference in San Francisco6
. Dehaier Medical Systems Acquires Emergency Ventilator Series to Extend Product Line7
. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity8
. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report9
. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity10
. Globus Medical Raises $110 Million in Series E Financing Round11
. Quark Pharmaceuticals Appoints New Chief Medical Officer